首页> 外文期刊>Annals of Coloproctology >Survival Rate and Prognostic Factors in Perforated Colorectal Cancer Patients: A Case-Control Study
【24h】

Survival Rate and Prognostic Factors in Perforated Colorectal Cancer Patients: A Case-Control Study

机译:穿孔大肠癌患者的生存率和预后因素:病例对照研究。

获取原文
           

摘要

Purpose Perforations are rare but serious complications in colorectal cancer. Controversy exists over whether to perform a radical operation because colorectal cancer perforation is considered as an advanced stage disease, and septic complications of peritonitis have been identified as being responsible for a poor prognosis. The aim of this study was to assess the correlation between the survival rate and the clinicopathological parameters that might be used as predictive factors of the prognosis for perforated colorectal cancer. Methods The analysis was based on 24 cases of perforated colorectal cancer (the case group), 48 cases of matching uncomplicated colorectal cancer (the control group), and 72 cases of the case and the control groups combined together (the combined group), all of which were identified during a 10-yr period in a single institution. Results The five-year survival rates of the perforated colorectal cancer patients and their matching controls were similar (P=0.484). No significant differences in the locations of the cancer, the pre-operative carcinoembryonic antigen (CEA) levels, the tumor sizes, the resection margins, or the numbers of the lymph nodes harvested were found between the two groups. A univariate analysis of the prognostic factors that influenced the case group revealed that adjuvant chemotherapy (P=0.004) was significantly correlated to a better five-year survival rate. A univariate analysis of the prognostic factors that influenced the five-year survival rate of the combined group revealed that the stage (P Conclusion The clinical pathway of perforated colorectal cancer is similar to that of uncomplicated colorectal cancer. Therefore, perforated colorectal cancer patients should be recommended for treatment with the appropriate radical operation and adjuvant chemotherapy based on oncologic principles.
机译:目的穿孔是结直肠癌中罕见但严重的并发症。关于是否进行根治性手术存在争议,因为结肠直肠癌穿孔被认为是晚期疾病,并且腹膜炎的败血性并发症已被认为是不良预后的原因。这项研究的目的是评估存活率与临床病理参数之间的相关性,这些参数可能被用作预测结直肠癌穿孔的预后因素。方法根据24例穿孔性大肠癌(病例组),48例符合条件的单纯性大肠癌(对照组),72例病例与对照组合并(合并组)进行分析。其中十年是在单个机构中确定的。结果穿孔大肠癌患者及其匹配对照组的五年生存率相似(P = 0.484)。两组之间在癌症部位,术前癌胚抗原(CEA)水平,肿瘤大小,切除切缘或淋巴结数目方面无显着差异。对影响病例组的预后因素的单因素分析显示,辅助化疗(P = 0.004)与更好的五年生存率显着相关。对影响合并组五年生存率的预后因素进行单因素分析后发现,分期(P结论)穿孔性大肠癌的临床路径与未并发症的大肠癌相似。因此,穿孔性大肠癌患者应建议根据肿瘤学原理进行适当的根治性手术和辅助化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号